Indian pharma export target worth USD 126 million in FY22 on blink amid Afghan crisis
Hyderabad: As uncertainty looms large in Afghanistan, Indian pharma exporters are apprehensive to send goods to the war-torn country and the target of exporting USD 126 million worth of pharmaceutical goods to the Taliban-ruling nation now depends on the future outcome.
Udaya Bhaskar, Director General of Pharmaceuticals Export Promotion Council of India (Pharmexcil) body under the Department of Commerce on Tuesday said as the situation is grim over there and India pharma exporters have cordial relations with Afghanistan.
"The projected target for 2021-22 is USD 126.22 million. The majority of it would be formulations and after that vaccines. Now with the present situation, exporters are apprehensive with regards to how the new regime will act upon. It is too early to comment on export targets," the official told PTI on Tuesday.
He, however, said there was no instruction from the centre to suspend exports to Afghanistan.
Read also: Pharma exports exclusion from RoDTEP scheme will hit competitiveness: Industry bodies
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.